3.20
price down icon2.44%   -0.08
 
loading

Opthea Limited Adr Borsa (OPT) Ultime notizie

pulisher
Nov 19, 2024

Opthea Limited Targets AMD Market with Sozinibercept - TipRanks

Nov 19, 2024
pulisher
Nov 15, 2024

Opthea Appoints Kathy Connell to Board of Directors - The Manila Times

Nov 15, 2024
pulisher
Nov 15, 2024

Opthea Appoints Kathy Connell to Board of Directors - GlobeNewswire Inc.

Nov 15, 2024
pulisher
Nov 15, 2024

Opthea : Chairman’s Address to the 2024 Annual General Meeting Form 6 K - Marketscreener.com

Nov 15, 2024
pulisher
Nov 14, 2024

Opthea Limited Announces Board Changes - Marketscreener.com

Nov 14, 2024
pulisher
Nov 12, 2024

Opthea's Wet AMD Program Featured at Ophthalmology Events - The Manila Times

Nov 12, 2024
pulisher
Nov 09, 2024

Opthea (NASDAQ:OPT) Shares Up 1.7% – What’s Next? - Defense World

Nov 09, 2024
pulisher
Nov 04, 2024

Opthea to Participate in November Investor Conferences - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Opthea : UPDATE Opthea to Participate in November Investor Conferences Form 6 K - Marketscreener.com

Nov 04, 2024
pulisher
Nov 01, 2024

Opthea Limited Strengthens Leadership and Advances AMD Treatment - TipRanks

Nov 01, 2024
pulisher
Oct 19, 2024

FY2025 EPS Estimates for Opthea Lifted by Leerink Partnrs - Defense World

Oct 19, 2024
pulisher
Oct 16, 2024

OPTOpthea Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Oct 16, 2024
pulisher
Oct 16, 2024

Is Opthea Limited (OPT) the Penny Stock with the Biggest Upside Potential According to Analysts? - Insider Monkey

Oct 16, 2024
pulisher
Oct 16, 2024

Opthea Files Notice of Annual General Meeting - The Manila Times

Oct 16, 2024
pulisher
Oct 12, 2024

Opthea Ltd stock soars to 52-week high, touches $4.95 - Investing.com India

Oct 12, 2024
pulisher
Oct 12, 2024

Opthea Ltd stock soars to 52-week high, touches $4.95 By Investing.com - Investing.com South Africa

Oct 12, 2024
pulisher
Oct 10, 2024

Opthea Wet AMD Program to be Presented at Innovate Retina - The Manila Times

Oct 10, 2024
pulisher
Oct 08, 2024

Opthea Appoints Chief Medical Officer and Chief Financial Officer as Company Prepares for Phase 3 Topline Data Readouts in 2025 - The Manila Times

Oct 08, 2024
pulisher
Oct 07, 2024

Opthea Limited Announces Chief Financial Officer Changes - Marketscreener.com

Oct 07, 2024
pulisher
Sep 30, 2024

Opthea to Participate in the UBS Virtual Ophthalmology Day 2024 - The Manila Times

Sep 30, 2024
pulisher
Sep 30, 2024

Opthea Advances Retinal Disease Treatments - TipRanks

Sep 30, 2024
pulisher
Sep 26, 2024

Opthea Advances nAMD Treatment with Sozinibercept - TipRanks

Sep 26, 2024
pulisher
Sep 23, 2024

Opthea Joins the S&P/ASX 300 Index - StockTitan

Sep 23, 2024
pulisher
Sep 19, 2024

Opthea Limited (NASDAQ:OPT) Shares Sold by Victory Capital Management Inc. - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

EX-99.1 - SEC.gov

Sep 18, 2024
pulisher
Sep 18, 2024

Opthea Advances Toward Sozinibercept Commercialization - TipRanks

Sep 18, 2024
pulisher
Sep 10, 2024

Opthea’s Sozinibercept Eyes Breakthrough in AMD Therapy - TipRanks

Sep 10, 2024
pulisher
Sep 07, 2024

FY2025 EPS Estimates for Opthea Limited Boosted by HC Wainwright (NASDAQ:OPT) - Defense World

Sep 07, 2024
pulisher
Sep 06, 2024

Research Analysts Set Expectations for Opthea Limited’s FY2029 Earnings (NASDAQ:OPT) - Defense World

Sep 06, 2024
pulisher
Sep 05, 2024

Opthea Prepares for Phase 3 Results with Leadership Revamp - TipRanks

Sep 05, 2024
pulisher
Sep 04, 2024

Opthea (NASDAQ:OPT) Given New $12.00 Price Target at HC Wainwright - Defense World

Sep 04, 2024
pulisher
Sep 03, 2024

Opthea Limited Showcases Innovations at Investor Conferences - TipRanks

Sep 03, 2024
pulisher
Aug 30, 2024

Opthea Limited: Revenues Up, Losses Widen - TipRanks

Aug 30, 2024
pulisher
Aug 30, 2024

Opthea Reports Full-Year Financial Results and Business Updates - Morningstar

Aug 30, 2024
pulisher
Aug 08, 2024

Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15, 2024 - Morningstar

Aug 08, 2024
pulisher
Aug 08, 2024

Opthea Limited Showcases at Ophthalmology Event - TipRanks

Aug 08, 2024
pulisher
Jul 17, 2024

Opthea forms global medical advisory board for retinal diseases - Investing.com India

Jul 17, 2024
pulisher
Jul 17, 2024

Opthea Welcomes International Retina Thought Leaders to Join Its Medical Advisory Board - StockTitan

Jul 17, 2024
pulisher
Jul 14, 2024

Why Atturra, Bravura, Core Lithium, and Opthea shares are racing higher today - The Motley Fool

Jul 14, 2024
pulisher
Jul 09, 2024

Opthea’s Sozinibercept Shows Promise for Wet AMD - TipRanks

Jul 09, 2024
pulisher
Jul 09, 2024

Opthea Announces Publication on VEGF-C and D Signaling Pathways as Potential Targets for Treatment of Wet AMD - StockTitan

Jul 09, 2024
pulisher
Jul 05, 2024

Opthea (NASDAQ:OPT) Shares Down 0.8% - Defense World

Jul 05, 2024
pulisher
Jul 02, 2024

Opthea Data for OPT-302 in Patients with Polypoidal Choroidal Vasculopathy (PCV) Presented at Angiogenesis 2022 - The Globe and Mail

Jul 02, 2024
pulisher
Jun 29, 2024

Opthea To Present at SVB Leerink Global Healthcare Conference - The Globe and Mail

Jun 29, 2024
pulisher
Jun 27, 2024

Opthea strengthens its Board of Directors - Quantisnow

Jun 27, 2024
pulisher
Jun 18, 2024

Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens - Morningstar

Jun 18, 2024
pulisher
Jun 15, 2024

Opthea raises $113.2 million to fund eye drug development - The Pharma Letter

Jun 15, 2024
pulisher
Jun 13, 2024

Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹) - Morningstar

Jun 13, 2024
pulisher
May 31, 2024

Opthea LimitedADR (OPT) Price Target Increased by 9.06% to 5.95 - MSN

May 31, 2024
pulisher
May 30, 2024

Market Insight: Opthea Limited ADR (OPT)'s Notable Drop, Closing at 3.00 – DWinneX - The Dwinnex

May 30, 2024
pulisher
May 28, 2024

2 Stocks Under $10 Wall Street Says Are 'Strong Buys' - Barchart

May 28, 2024
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):